Oligo-Cobalt
Natural health product licensed in Canada
- Licence holder
- Laboratoire Schmidt-Nagel Inc.
- NPN or DIN-HM
- 80022779
- Status
- Active licence
- Licence date
- 13 December 2010
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- TPD Cat IV/LS
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Alcool éthylique, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 mL | 1 Tous les jours |
Uses authorised in Canada
Remède oligothérapeutique devant être utilisé sur recommandation d`un praticien de la santé.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consultez un praticien de la santé si les symptômes persistent ou s`aggravent. Consultez un praticien de la santé avant usage si vous prenez un supplément qui contient de la vitamine B12. Cessez l`utilisation et consultez un praticien de la santé si des troubles gastro-intestinaux et/ou une éruption cutanée se manifestent. Ne pas utiliser si le sceau est brisé. Conditions normales d`entreposage.
- Contre-indications
Ne pas utiliser si vous êtes enceinte ou si vous allaitez sauf sur la recommandation d`un praticien de la santé. Ne pas utiliser si vous présentez une carence en iode.
Source
Official Health Canada record, licence 80022779
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.